About Ultra BiOmics

UltraBiomics focuses on making good metabolic health accessible to individuals. The company provides services aimed at supporting and improving users' overall metabolic well-being. This offering is designed to help people achieve and maintain long, healthy lives.

```xml <problem> Metabolic disorders like diabetes and obesity are often diagnosed late, after significant health deterioration. Traditional blood tests may not reveal the underlying causes of these disorders, leaving many individuals with undiagnosed symptoms and a progressive decline in health. Current diagnostic methods may lack the personalized insights needed for effective, targeted interventions. </problem> <solution> Ultra BiOmics offers gut microbiome and metabolomic testing to identify the root causes of metabolic dysfunction, enabling earlier diagnosis and personalized treatment. By analyzing both the gut microbiome and metabolomic profiles, Ultra BiOmics provides a comprehensive view of a patient's metabolic health, highlighting failing pathways and risk areas. The company's evidence-based approach delivers actionable insights that empower clinicians to choose the most effective treatments and interventions. This allows for targeted interventions that can improve patient outcomes and potentially reverse the progression of metabolic diseases. Ultra Biomics equips practitioners with previously inaccessible insights, facilitating a more proactive and personalized approach to managing metabolic health. </solution> <features> - Comprehensive testing of both gut microbiome and metabolomic profiles for a holistic view of metabolic health. - Identification of failing metabolic pathways and risk areas to pinpoint the root causes of dysfunction. - Evidence-based insights derived from curated, high-quality research. - Personalized recommendations for targeted treatments and interventions. - Detailed reports providing clinicians with actionable insights into their patient's metabolic health. - Monitoring of treatment effectiveness through follow-up testing and tracking of improvements. </features> <target_audience> Ultra BiOmics targets clinicians and practices seeking to improve patient outcomes in metabolic health, as well as individuals experiencing undiagnosed symptoms or seeking to optimize their healthspan. </target_audience> ```

What does Ultra BiOmics do?

Where is Ultra BiOmics located?

Ultra BiOmics is based in London, United Kingdom.

When was Ultra BiOmics founded?

Ultra BiOmics was founded in 2024.

Who founded Ultra BiOmics?

Ultra BiOmics was founded by Asam Rafi and Lisa Rickers.

Asam Rafi - Co-Founder/CCO
Lisa Rickers - Co-Founder/CEO

Location

London, United Kingdom

Founded

2024

Employees

3 employees

Ultra BiOmics

London, United KingdomFounded 20243500+ followers6/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.

Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Metabolic disorders like diabetes and obesity are often diagnosed late, after significant health deterioration. Traditional blood tests may not reveal the underlying causes of these disorders, leaving many individuals with undiagnosed symptoms and a progressive decline in health. Current diagnostic methods may lack the personalized insights needed for effective, targeted interventions.

Solution

Ultra BiOmics offers gut microbiome and metabolomic testing to identify the root causes of metabolic dysfunction, enabling earlier diagnosis and personalized treatment. By analyzing both the gut microbiome and metabolomic profiles, Ultra BiOmics provides a comprehensive view of a patient's metabolic health, highlighting failing pathways and risk areas. The company's evidence-based approach delivers actionable insights that empower clinicians to choose the most effective treatments and interventions. This allows for targeted interventions that can improve patient outcomes and potentially reverse the progression of metabolic diseases. Ultra Biomics equips practitioners with previously inaccessible insights, facilitating a more proactive and personalized approach to managing metabolic health.

Target Audience

Ultra BiOmics targets clinicians and practices seeking to improve patient outcomes in metabolic health, as well as individuals experiencing undiagnosed symptoms or seeking to optimize their healthspan.

Features

Comprehensive testing of both gut microbiome and metabolomic profiles for a holistic view of metabolic health.
Identification of failing metabolic pathways and risk areas to pinpoint the root causes of dysfunction.
Evidence-based insights derived from curated, high-quality research.
Personalized recommendations for targeted treatments and interventions.
Detailed reports providing clinicians with actionable insights into their patient's metabolic health.
Monitoring of treatment effectiveness through follow-up testing and tracking of improvements.